Comparison of tacrolimus and cyclosporin therapy in heart transplantation

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-001041-83

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

To investigate changes in subcellular markers of growth, apoptosis, differentiation, survival, inflammation and oxidative stress, in relationship with cellular acute rejection, in de novo cardiac transplant recipients receiving either tacrolimus or cyclosporine as primary immunosuppressant.


Critère d'inclusion

  • Cardiac transplant recipients

Liens